William J. Kerr
295 Cathedral Street, G1 1XL
Glasgow, SCT, United Kingdom
Glasgow, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Targeting Activin Receptor-like Kinase 2 Using Heterobifunctional Protein Degraders.
Journal: Journal of medicinal chemistry
Published: May 04, 2026
Structure-Activity Relationship Studies Resulting in the Identification of Potent and Selective Salt-Inducible Kinase Inhibitors.
Journal: ACS medicinal chemistry letters
Published: April 09, 2026
Comparing the efficacy of cipaglucosidase alfa plus miglustat with alglucosidase alfa for late-onset Pompe disease: an expanded network meta-analysis utilizing patient-level and aggregate data.
Journal: Journal of comparative effectiveness research
Published: February 27, 2026
Advancing Isotope Labeling Technologies at AstraZeneca through Academic-Industrial Collaboration.
Journal: ACS medicinal chemistry letters
Published: May 30, 2025
Nitrile-tolerant Iridium-catalysed Hydrogen Isotope Exchange.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: February 04, 2025
Probing substrate binding and release events in iridium-catalysed hydrogen isotope exchange reactions.
Journal: Chemical science
Published: January 28, 2025
Global airway disease: mepolizumab simultaneously improves outcomes in severe CRSwNP and asthma.
Journal: Rhinology
Published: December 11, 2024
Selective Deuteration and Tritiation of Pharmaceutically Relevant Sulfoximines.
Journal: Angewandte Chemie (International ed. in English)
Published: September 06, 2024
C-H Activation and Hydrogen Isotope Exchange of Aryl Carbamates Using Iridium(I) Complexes Bearing Chelating NHC-Phosphine Ligands.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: August 16, 2024
Collaborative GSK-University of Strathclyde doctoral research and training programmes: Transforming approaches to industry-academia engagement.
Journal: Drug discovery today
Published: July 18, 2024
Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study.
Journal: Current medical research and opinion
Published: July 08, 2024
Last Updated: 09/26/2026